INVENT Pharmaceuticals
"transforming molecules to medicines"
INVENT Pharmaceuticals is developing novel and innovative small molecule drugs for the the treatment of serious diseases with high unmet medical need to help improve patients quality of life.
INVENT Pharmaceuticals is advancing the development of its differentiated therapeutics for the treatment of Cardiometabolic, Obesity, Weight Reduction, Pulmonary Aerterial Hypertension (PAH), Resistant Hypertension, and Renal diseases (CKD), Liver Fibrosis, Alzheimer's diseases, Neuropsychiatric disorders, Attention Deficit Hyperactivity Disorders (ADHD), General Anxiety Disorder (GAD) and Major Depressive Disorders MDDI, Neuroendocrine Tumors and SARS-CoV-2.
We are dedicated to helping improve lives of patients by inventing and providing best-in-class and first-in-class medicines.